Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.
about
Carvedilol versus non-selective beta-blockers for portal hypertension in cirrhosisSystemic hemodynamics in advanced cirrhosis: Concerns during perioperative period of liver transplantationInhibition of vascular endothelial growth factor signaling facilitates liver repair from acute ethanol-induced injury in zebrafishHepatic congestion leads to fibrosis: findings in a newly developed murine model.Effects of Electroacupuncture Stimulation at "Zusanli" Acupoint on Hepatic NO Release and Blood Perfusion in MiceValue of portal venous system radiological indices in predicting esophageal varicesRenal dysfunction in cirrhosis.Nitric oxide in liver diseases.Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis.Cellular distribution of injected PLGA-nanoparticles in the liver.Adipocytokines and hepatic fibrosis.Complications of cirrhosis. A 50 years flashback.Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments.Antifibrotic therapies in the liver.Cirrhotic Multiorgan Syndrome.Glucose as a stimulation agent in the BOLD functional magnetic resonance imaging for liver cirrhosis and hepatocellular carcinoma: a feasibility study.Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights.Diastolic dysfunction in cirrhosis.Angiogenesis and Fibrogenesis in Chronic Liver Diseases.Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon.Hepatitis C virus induced tumor initiating cancer stem-like cells activate stromal fibroblasts in xenograft tumor model.The frequency of acute kidney injury in patients with chronic hepatitis C virus infection treated with sofosbuvir-based regimens.Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study.Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS.Anti-fibrotic effects of neferine on carbon tetrachloride-induced hepatic fibrosis in mice.Changes in Hepatic Venous Pressure Gradient Induced by Physical Exercise in Cirrhosis: Results of a Pilot Randomized Open Clinical TrialProtective effects of Foeniculum vulgare root bark extract against carbon tetrachloride-induced hepatic fibrosis in mice.Micro-HCCs in rats with liver cirrhosis: paradoxical targeting effects with vascular disrupting agent CA4P.Understanding the Pathophysiology of Portosystemic Shunt by Simulation Using an Electric Circuit.Dynamic regulation of canonical TGFβ signalling by endothelial transcription factor ERG protects from liver fibrogenesis.Portal vein reconstruction using vein grafts in pediatric living donor liver transplantation: Current status.Cytokines, hepatic cell profiling and cell interactions during bone marrow cell therapy for liver fibrosis in cholestatic mice.Pathological process of liver sinusoidal endothelial cells in liver diseases.The beneficial effects of curcumin in cirrhotic rats with portal hypertension.Biology of portal hypertension.The pathology of eclampsia: An autopsy series.The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis.Intrahepatic angiogenesis increases portal hypertension in hepatitis B patients with cirrhosis.Assessment of Advanced Liver Fibrosis and the Risk for Hepatic Decompensation in Patients with Congestive Hepatopathy.Hypoxic-ischemic gene expression profile in the isolated variant of biliary atresia.
P2860
Q24186341-18E002D8-1490-4AFC-A62E-B9771C2EF618Q28076547-7B23D90A-A124-4380-B1C4-623706734F23Q28820975-4E9317DB-399C-4F5A-8AB2-AF243AD2AB64Q35001914-34375937-1193-4391-AD7D-02A645013909Q35013070-478F458F-C41B-4077-B314-23E7599B1E2EQ35087860-968A959D-80B8-4CEA-A941-E3E589DA604FQ35559713-F46F86AC-9B45-4657-B4E3-88E4E719CFB4Q35940869-EA79BB97-1D4C-4F14-886A-5ADEEE5E53F8Q36393781-6190A351-E2DE-4356-A7D2-56507E80664CQ36957725-1A2CCC0B-03C6-48A3-8777-A18A635F87C9Q38346026-376FC6BC-A1C7-42F1-B372-938FF55377B5Q38424360-EECCB77C-4327-48ED-8F94-81932736ABD7Q38446357-3B7C0FAD-82E9-4206-8AFA-7B3844D0BC0EQ38480164-FB425E6A-1104-4B54-A1F0-ADE11CF427C7Q38538183-C0E677D6-CBC9-4283-B0A7-81176EB20C7EQ38668818-1E44500C-111E-47E4-A5F1-04A5269017CBQ38759447-47DF3814-A0CE-4F8A-9D66-31ED2ACFCD5CQ38881630-312655FE-902B-4E61-B729-2F0C36274C62Q39140170-46220AC8-90CE-4841-BDFA-A7017C659F5CQ39429850-89A93F45-6390-4092-97F3-5AD26A521DC1Q40140008-BE595C4F-0B30-4DAB-B000-D7AA030A7A37Q40215846-32849708-1504-494F-BE27-2BF2765E1D39Q40285529-85DFACAE-0B17-406E-8208-8B7A1D9AAE24Q40772599-C674FDC9-982E-45E5-850F-2130074D7C04Q41175370-21F16406-C27F-4164-9469-E472F50480F8Q41247731-4236FAA9-D773-45F7-B22F-33B4F2B6B9CDQ41505591-23A83051-700B-48EA-BB50-F9EA2CBA4E7BQ41549134-03B823B7-5CD9-4A22-81BA-6593667E8C29Q42069893-9FF60B61-F93C-44DC-807D-0340D563D50DQ42375998-E6DF78F8-4E3A-412C-A710-39B81F9C1C89Q46153006-B86DF698-8AF2-489D-993B-77EB91393C04Q47104873-72F3B91A-AA53-4882-9BBE-FFC8F791249AQ47140147-EAC92142-A613-4169-917A-98FE1217C058Q47377507-889BF720-5BA5-4265-9203-9A52C4CE4948Q47874043-75CF4C3C-50E0-406D-BFDA-1D7275D3A992Q48210918-D499A399-17B6-49AB-A937-56D175EA3B33Q48331734-C652B599-6D02-4444-96E2-7784472CFA48Q50242973-B1A652D7-CDBA-439A-AA5C-2CCF4350960CQ52577723-F5A9C1AC-03EB-499C-8A07-C0E974E1B8EAQ53302744-AB30A821-9E70-464E-B96A-29AFCCEFC0BD
P2860
Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Vascular pathobiology in chron ...... status and future directions.
@ast
Vascular pathobiology in chron ...... status and future directions.
@en
type
label
Vascular pathobiology in chron ...... status and future directions.
@ast
Vascular pathobiology in chron ...... status and future directions.
@en
prefLabel
Vascular pathobiology in chron ...... status and future directions.
@ast
Vascular pathobiology in chron ...... status and future directions.
@en
P2093
P2860
P1476
Vascular pathobiology in chron ...... status and future directions.
@en
P2093
Don C Rockey
Vijay Shah
Yasuko Iwakiri
P2860
P304
P356
10.1016/J.JHEP.2014.05.047
P577
2014-06-06T00:00:00Z